glimepiride has been researched along with Congenital Myotonic Dystrophy in 1 studies
glimepiride: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"It is important to choose the optimal treatment for DM in myotonic dystrophy, because the patients have hyperinsulinemia caused by specific mechanism and could not reduce the insulin resistance." | 5.33 | Low-dose metformin improves hyperglycaemia related to myotonic dystrophy. ( Komiya, I; Kouki, T; Nakachi, A; Takasu, N; Tamanaha, T; Tawata, M, 2005) |
"It is important to choose the optimal treatment for DM in myotonic dystrophy, because the patients have hyperinsulinemia caused by specific mechanism and could not reduce the insulin resistance." | 1.33 | Low-dose metformin improves hyperglycaemia related to myotonic dystrophy. ( Komiya, I; Kouki, T; Nakachi, A; Takasu, N; Tamanaha, T; Tawata, M, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kouki, T | 1 |
Takasu, N | 1 |
Nakachi, A | 1 |
Tamanaha, T | 1 |
Komiya, I | 1 |
Tawata, M | 1 |
1 other study available for glimepiride and Congenital Myotonic Dystrophy
Article | Year |
---|---|
Low-dose metformin improves hyperglycaemia related to myotonic dystrophy.
Topics: Blood Glucose; C-Peptide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin | 2005 |